Back to directory
Country
Sweden
City
—
Founded
—
Headcount
11-50
stockholm
Description
Moleculent develops technology that maps cell–cell communication directly within human tissue, giving researchers a new way to study disease.
Funding history
-
Series A 2026-05-04
Lead Rubicon Healthcare Partners
Investors Rubicon Healthcare Partners, ARCH Venture Partners, Eir Ventures
Moleculent develops technology that maps cell–cell communication directly within human tissue, giving researchers a new way to study disease.
$20,000,000
Source
Founders
-
Emma Lundberg